Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist-Reference-Cited by-同舟云学术

Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist

Published:1995-10 Issue:2 Volume:285 Page:181-188
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Mizuno Makoto,Sada Toshio,Ikeda Masahiro,Fukuda Norio,Miyamoto Masaaki,Yanagisawa Hiroaki,Koike Hiroyuki

Publisher

Elsevier BV

Subject

Pharmacology

Reference14 articles.

1. Nomenclature for angiotensin receptors;Bumpus;Hypertension,1991

2. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats;Bunkenburg;Hypertension,1992

3. Severe angioedema after long-term use of an angiotensin-converting enzyme inhibitor;Chin;Ann. Intern. Med.,1990

4. Identification of angiotensin II receptor subtypes;Chiu;Biochem. Biophys. Res. Commun.,1989

5. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent;Chiu;J. Pharmacol. Exp. Ther.,1990

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of MGS0274, an ester prodrug of a metabotropic glutamate receptor 2/3 agonist with improved oral bioavailability;European Journal of Medicinal Chemistry;2020-10

2. Current Advances in the Synthesis and Biological Evaluation of Pharmacologically Relevant 1,2,4,5-Tetrasubstituted-1H-Imidazole Derivatives;Current Organic Chemistry;2019-12-19

3. Linalyl acetate prevents olmesartan-induced intestinal hypermotility mediated by interference of the sympathetic inhibitory pathway in hypertensive rat;Biomedicine & Pharmacotherapy;2018-06

4. Olmesartan medoxomil/amlodipine/hydrochlorothiazide 20 mg/5 mg/12.5 mg fixed-dose combination in hypertension: a profile of its use;Drugs & Therapy Perspectives;2017-12-04

5. Olmesartan medoxomil: a guide to its use as monotherapy or in fixed-dose combinations with amlodipine and/or hydrochlorothiazide;Drugs & Therapy Perspectives;2016-08-12